US 12,728,149 B2
Pharmaceutical composition for preventing and treating depression, comprising herbal medicine complex extracts of Zizyphi spinosi Semen, Jujubae Fructus, Hordei Fructus Germinatus, Glycyrrhizae Radix et Rhizoma, Angelicae Gigantis Radix, and Beta vulgaris as active ingredients
Jin Han Park, Daegu (KR); and Ki Han Kwon, Gyeongsan-si (KR)
Assigned to INDUSTRY-ACADEMIC COORPERATION FOUNDATION DAEGU HAANY UNIVERSITY, Gyeongsan-si (KR)
Filed by INDUSTRY-ACADEMIC COORPERATION FOUNDATION DAEGU HAANY UNIVERSITY, Gyeongsan-si (KR)
Filed on Dec. 28, 2023, as Appl. No. 18/398,843.
Claims priority of application No. 10-2023-0026580 (KR), filed on Feb. 28, 2023.
Prior Publication US 2024/0285720 A1, Aug. 29, 2024
Int. Cl. A61K 36/21 (2006.01); A61K 36/232 (2006.01); A61K 36/484 (2006.01); A61K 36/725 (2006.01); A61K 36/8998 (2006.01); A61P 25/24 (2006.01)
CPC A61K 36/8998 (2013.01) [A61K 36/21 (2013.01); A61K 36/232 (2013.01); A61K 36/484 (2013.01); A61K 36/725 (2013.01); A61P 25/24 (2018.01); A61K 2236/331 (2013.01)] 3 Claims
 
1. A method for treating depression, comprising administering to a subject in need thereof a composition comprising an active ingredient consisting of extracts of Zizyphi spinosi Semen, Jujubae Fructus, Hordei Fructus Germinatus, Glycyrrhizae Radix et Rhizoma, Angelicae Gigantis Radix, and Beta vulgaris,
wherein the subject requires increasing a protein expression of Brain-Derived Neurotrophic Factor, Extracellular Signal-Regulated Kinase and cAMP Response Element-Binding Protein.